BenzingaThu, 07 May 2026 17:53:28 GMTImmunityBio Stock Drops After Earnings Miss Despite Anktiva MomentumIBRX+0.06%
Zacks Investment ResearchThu, 07 May 2026 13:55:49 GMTImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue EstimatesIBRX+0.06%
Zacks Investment ResearchMon, 04 May 2026 18:10:16 GMTImmunityBio to Report Q1 Earnings: What's in the Cards?IBRX+0.06%
Zacks Investment ResearchMon, 27 Apr 2026 17:36:18 GMTIBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 CatalystsIBRX+0.06%
Zacks Investment ResearchMon, 27 Apr 2026 17:30:37 GMTIBRX: What Anktiva's Bladder Data Says About 2026 SalesIBRX+0.06%
Zacks Investment ResearchMon, 27 Apr 2026 17:30:30 GMTIs IBRX Priced for Perfection at Nearly 28x Forward Sales?IBRX+0.06%
Zacks Investment ResearchMon, 27 Apr 2026 17:02:22 GMTWhat Makes ImmunityBio (IBRX) a New Buy StockIBRX+0.06%
BenzingaTue, 21 Apr 2026 13:44:07 GMTImmunityBio Stock Rises As ANKTIVA Launches in Saudi ArabiaIBRX+0.06%
Seeking AlphaFri, 17 Apr 2026 11:49:30 GMTReframing ImmunityBio: The Long-Term Platform Opportunity Beyond AnktivaIBRX+0.06%
Zacks Investment ResearchFri, 10 Apr 2026 19:55:25 GMTIBRX Stock Rises 7% on Strong Q1 2026 Preliminary ResultsIBRX+0.06%
Zacks Investment ResearchTue, 07 Apr 2026 14:01:47 GMTIBRX Responds to FDA Warning Over Misleading Cancer Drug ClaimsIBRX+0.06%
BenzingaThu, 26 Mar 2026 14:04:08 GMTImmunityBio Lead Bladder Cancer Drug Trial Clears Power CheckIBRX+0.06%
Zacks Investment ResearchWed, 25 Mar 2026 16:31:27 GMTWhy Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?IBRX+0.06%
Zacks Investment ResearchWed, 25 Mar 2026 13:25:22 GMTIBRX Stock Slides on FDA Warning Over Misleading Cancer Drug ClaimsIBRX+0.06%
InvezzTue, 24 Mar 2026 19:25:23 GMTImmunityBio stock price crash: buy the dip or sell the rip?IBRX+0.06%
Zacks Investment ResearchTue, 24 Mar 2026 17:46:24 GMTImmunityBio Rises on China Nod to Bladder Cancer Combo TherapyIBRX+0.06%
The Motley FoolTue, 24 Mar 2026 16:39:03 GMTWhy ImmunityBio Stock Is Down More Than 20% TodayIBRX+0.06%
BenzingaTue, 24 Mar 2026 15:04:29 GMTImmunityBio Crashes On FDA Warning Over Anktiva ClaimsIBRX+0.06%
